Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2
- PMID: 12114747
- DOI: 10.1385/ep:13:1:17
Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2
Abstract
Pheochromocytomas are rare neuroendocrine tumors that arise from chromaffin tissue. In a small subset of patients, pheochromocytomas occur as a manifestation of von Hippel- Lindau (VHL) disease. The histology of VHL-associated pheochromocytomas has not been reported in detail. In this article, we describe histopathologic features of 14 pheochromocytomas in eight patients with VHL disease and demonstrate that VHL-associated pheochromocytomas have a distinct histologic phenotype as compared with pheochromocytomas in patients with multiple endocrine neoplasia type 2 (MEN 2). VHL tumors are characterized by a thick vascular tumor capsule; myxoid and hyalinized stroma; round, small to medium tumor cells intermixed with small vessels; predominantly amphophilic and clear cytoplasm; absence of cytoplasmic hyaline globules; and lack of nuclear atypia or mitoses. In contrast to MEN 2, there is no extratumoral adrenomedullary hyperplasia in the VHL adrenal gland. Our findings of a distinct histologic phenotype of VHL pheochromocytoma may further help in subdividing patients who clinically present with multiple, bilateral pheochromocytomas.
Similar articles
-
Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.J Clin Endocrinol Metab. 2005 Jun;90(6):3747-51. doi: 10.1210/jc.2004-1899. Epub 2005 Mar 15. J Clin Endocrinol Metab. 2005. PMID: 15769989
-
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.J Clin Endocrinol Metab. 2001 May;86(5):1999-2008. doi: 10.1210/jcem.86.5.7496. J Clin Endocrinol Metab. 2001. PMID: 11344198
-
Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.Horm Metab Res. 2007 Dec;39(12):876-83. doi: 10.1055/s-2007-993135. Epub 2007 Nov 28. Horm Metab Res. 2007. PMID: 18046660
-
Von Hippel-Lindau disease: a single gene, several hereditary tumors.J Endocrinol Invest. 2018 Jan;41(1):21-31. doi: 10.1007/s40618-017-0683-1. Epub 2017 Jun 6. J Endocrinol Invest. 2018. PMID: 28589383 Review.
-
[Bilateral pheochromocytomas with von Hippel-Lindau's disease: a case report].Nihon Hinyokika Gakkai Zasshi. 1998 Aug;89(8):726-9. doi: 10.5980/jpnjurol1989.89.726. Nihon Hinyokika Gakkai Zasshi. 1998. PMID: 9780658 Review. Japanese.
Cited by
-
Familial pheochromocytomas and paragangliomas: stories from the sign-out room.Endocr Pathol. 2006 Winter;17(4):337-44. doi: 10.1007/s12022-006-0005-1. Endocr Pathol. 2006. PMID: 17525482
-
Head and neck paraganglioma in Pacak-Zhuang syndrome.JNCI Cancer Spectr. 2025 Jan 3;9(1):pkaf001. doi: 10.1093/jncics/pkaf001. JNCI Cancer Spectr. 2025. PMID: 39821441 Free PMC article.
-
Neuropathologic features of central nervous system hemangioblastoma.J Pathol Transl Med. 2022 May;56(3):115-125. doi: 10.4132/jptm.2022.04.13. Epub 2022 May 3. J Pathol Transl Med. 2022. PMID: 35501672 Free PMC article. Review.
-
Mosaicism in von Hippel-Lindau disease: an event important to recognize.J Cell Mol Med. 2007 Nov-Dec;11(6):1408-15. doi: 10.1111/j.1582-4934.2007.00122.x. J Cell Mol Med. 2007. PMID: 18205710 Free PMC article.
-
Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations.Br J Cancer. 2013 Feb 5;108(2):429-37. doi: 10.1038/bjc.2012.538. Epub 2012 Dec 20. Br J Cancer. 2013. PMID: 23257898 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical